Tevogen Bio, the company’s lead initiative, has completed a proof-of-concept clinical trial demonstrating the potential of its single-HLA-restricted, genetically unmodified allogeneic T cells. The ...

ai-pocalypse The jury is still out when it comes to determining how much job loss AI is causing. However, we now have another ...

The main market opportunities in the predictive analytics and maintenance sector within supply chains revolve around the ...

The market expects Udemy, Inc. (UDMY) to deliver a year-over-year decline in earnings on lower revenues when it reports ...

The article explores how AI, surveillance and weak enforcement are turning personal data into predictive tools, making ...

The organizations that understand the hidden ROI can scale faster, execute cleaner and operate with more confidence.

Dengue is becoming a bigger challenge in many parts of the world, including Latin America, as the factors that influence mosquito-borne disease continue to shift. McCord noted that in the Amazon and ...

In an interview with Markt & Technik, Rich Simoncic, Microchip Technology's COO, explains that edge AI tends to fail more due ...